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ABSTRACT 
Induction of Differentiation of Dental Pulp-Derived Mesenchymal Stem Cells 
(DPSC) 
 
By 
Aubrey Young 
 
Dr. Karl Kingsley, Examination Committee Chair 
Associate Professor of Biomedical Sciences 
Director of Student Research  
University of Nevada, Las Vegas 
 School of Dental Medicine 
 
Mesenchymal stem cells are derived from a variety of human tissues and are 
being bioengineered and studied for possible uses in the advancement of medicine. 
Recent efforts are being focused on Dental Pulp Stem Cells (DPSC’s) due to the 
accessibility of this tissue. Many factors inﬂuence DPSC quality and quantity, including 
the speciﬁc methods used to isolate, collect, concentrate, and store these isolates once 
they are removed. Ancillary factors, such as the choice of media, the selection of early 
versus late passage cells, and cryopreservation techniques may also influence the 
differentiation potential and proliferative capacity of DPSC isolates.   
The objective of this study was to evaluate the potential to induce differentiation 
of DPSC isolates in vitro by the adding of exogenous growth factors (GF), and by the 
coating of specific extracellular matrix molecules (ECM) onto the surface of tissue-
culture dishes. Photomicroscopy and mRNA analysis demonstrated the addition of TGF-
β1 notably increased pluripotency biomarkers in DPSC lines. The addition of 
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Dexamethasone (Dex) or plating on Laminin-5 (LN5) was correlated with changes to 
cellular morphology and cell size in different subsets of cells. RNA isolated from these 
DPSCs for relative endpoint (RE) reverse transcription polymerase chain reaction (RT-
PCR) revealed mRNA DPSC specific intracellular biomarkers (Klf4, Sox-2, Bin-1, 
Rnf12, Oct-4 and NANOG) and the cell surface marker (CD133) were enhanced 
following the administration of TGF- β 1 and were differentially down-regulated 
following Dexamethasone and Laminin-5 administration. This study provides some 
initial evidence that randomly selected DPSC isolates may be induced by established 
protocols to change phenotype and expression of pluripotent biomarkers with variable 
susceptibility between differing types of DPSCs. More studies will be needed to 
determine the range of cell types that can be successfully re-engineered in laboratory 
settings. 
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CHAPTER 1 
INTRODUCTION 
Background and Significance 
The isolation of mesenchymal stem cells (MSC) is an important scientific 
endeavor in the health sciences [1, 2]. Although much is known about embryonic stem 
cells and their regenerative capacity, recent efforts have focused on MSC because they 
are far less controversial, and more importantly, may be derived directly from children 
and adult patients [3, 4]. Many tissues, including bone marrow, peripheral blood, heart 
tissue, and lung tissue, harbor populations of viable MSCs but more recent efforts have 
focused on more accessible sources such as adipose tissue and dental pulp from extracted 
teeth [5-9].  
A growing body of evidence has suggested that dental pulp-derived stem cells 
(DPSC) are among the most accessible of human stem cell populations [10]. DPSCs are 
originally formed from both epithelial and mesenchymal stem cell progenitors, the 
epithelial-derived ameloblasts and the mesenchymal-derived dentin and bone and soft 
tissues of the periodontium [11]. Although they cannot form all cells and tissues of the 
body, these DPSCs are capable of differentiation into more than one cell type and are 
therefore classified as multipotent stem cells [12]. Studies have now confirmed DPSC, 
under specific conditions and stimuli, may be capable of differentiating into adipocytes, 
neurons, osteoblasts and chondrocytes although these specific methods could vary by 
whether the DPSC were derived from the apical part of the papilla (AP-DPSC), the dental 
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follicle (DF-DPSC) surrounding third molars, or the periodontal ligament (PDL-DPSC) 
[13,14].  
Two nation-wide commercial companies now offer a service for processing and 
storing DPSC from either primary teeth or extracted adult teeth, but little information is 
known about the differentiation potential of these DPSC isolates [15]. Hung E. et al. 
found that premolars and other intact teeth extracted from orthodontic patients ages 18-25 
exhibited the greatest likelihood for obtaining viable DPSC isolates [16]. These studies, 
however, did not evaluate the potential to induce differentiation in these uncommitted 
DPSC lines using established methods and protocols.  
Statement of Purpose 
The objective of this study was to evaluate the potential to induce differentiation 
of DPSC isolates originally derived from extracted teeth of adult orthodontic patients. 
The working hypothesis for this project was that any DPSC isolate, derived from vital, 
intact permanent adult teeth, could be induced towards differentiation in vitro using 
preplated cell-matrix adhesion molecules and the administration of exogenous growth 
factors [17, 18].  
Orthodontic patients whose treatment includes extractions of teeth should be 
educated about the opportunity they have to have their DPSCs banked and stored for 
possible use in their future. As orthodontic professionals we have an ethical responsibility 
to educate our patients about the benefits of stem cell banking. Understanding more about 
how to create usable stem cell isolates will further the progress of regenerative medicine 
and will better enable dental care providers to offer valuable education to our patients.  
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Research Questions and Hypotheses 
1. Dental pulp-derived mesenchymal stem cells (DPSC) can be directed towards a 
differentiated phenotype in vitro. 
     H0: No, potential DPSC isolates cannot be directed towards differentiation in vitro. 
     HA: Yes, potential DPSC isolates can be directed towards differentiation in vitro. 
2. Specific ECM and GF promote differentiation of dental pulp stem cells in vitro. 
     H0: No, specific ECM and GF do not promote differentiation of DPSC in vitro. 
     HA: Yes, specific ECM and GF do promote differentiation of DPSC in vitro. 
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CHAPTER 2 
LITERATURE REVIEW 
Many organs and tissues require the ability to replace cells as a normal part of the 
aging process, as well as in response to damage, injury or infection [19]. Research has 
now revealed that many of these organ and tissue systems have resident populations of 
somatic stem cells, which are capable of asymmetrical replication [20]. The process of 
asymmetric replication results in two daughter cells – one that retains the undifferentiated 
stem cell properties and the other that is capable of replacing dead, dying or injured cells 
[21]. 
Each of the primary germ layers of the developing embryo, ectoderm (or outside 
layer), endoderm (or inside layer) and mesoderm (or middle layer) give rise to tissues that 
will ultimately host their own populations of resident stem cells [22]. These tissue-
specific stem cell populations maybe further classified, based upon their potential for 
differentiation into the various cell types found within the tissue or organ system [23]. 
Although totipotent stem cells from embryonic tissues are capable of differentiating into 
every possible cell type found within the body, these are typically harvested from 
developmental or fetal tissues – which may limit their availability and potential for 
therapeutic use [24]. Most adult tissues host other types of stem cells, including 
multipotent, pluripotent and oligopotent stem cells capable of differentiation into more 
than one cell type, as well as unipotent stem cells that produce specialized cells of only 
one type [25]. 
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Although adult stem cells may be harvested and retrieved from a variety of tissues 
and organs, this may involve costly and invasive procedures, such as bone marrow or 
liposuction aspiration [26]. However, recent clinical studies have shown that dental pulp 
from extracted teeth may provide an abundant supply of highly proliferative, multipotent 
Mesenchymal Stem Cells (MSC), which are now known to be capable of regenerating a 
variety of human tissues including bone and other dental structures [27]. In addition, 
dental pulp-derived stem cells (DPSC) have also been demonstrated to be capable of 
differentiating into many other lineages, including osteoblasts, chondroblasts, adipocytes, 
as well as vascular and neural tissues [28].  
Sources 
Many factors are known to influence DPSC quantity and quality, although one of 
the most basic may be the source of the dental pulp itself [14]. For example, some 
evidence has recently emerged demonstrating that stem cells from human exfoliated 
deciduous (or primary) teeth (SHED) may exhibit faster growth and proliferation, as well 
as a more expansive array of potential cellular phenotypes and differentiation potentials 
[29]. Additionally, SHED may also exhibit slightly greater rates of survival after short-
term freezing and storage than DPSCs derived from extracted, permanent (adult) teeth 
[30]. However, due to the recent nature of these discoveries, the vast majority of the 
population is not able to make use of these reservoirs as they have already developed 
their permanent dentition, and those currently in need of stem cell therapy are unlikely to 
have had an opportunity to save any viable dental pulp from exfoliated primary teeth 
[31]. Moreover, some studies have provided evidence that the quantity of healthy pulp 
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derived from primary or deciduous teeth may, in fact, be insufficient to productively 
harvest SHED [32]. 
Based upon this knowledge, many researchers are now focused on exploring the 
role of permanent or adult teeth as a reservoir for the acquisition of DPSCs [33]. One 
possible source of DPSCs from healthy, permanent, adult tooth extraction are orthodontic 
clinics, where extraction of premolars and molars remains common practice among the 
four million patients in the United States often approaching or exceeding 30% of all 
patients [34]. Although no comprehensive review of DPSC by tooth type has been 
performed, recent work by this group has revealed that tooth type did not affect either 
quality or quantity of DPSC isolates, however, the age of donor was found to be a 
significant factor [16]. In fact, the most recent study provides further evidence that 
permanent teeth extracted from younger donors may yield DPSCs with higher growth, 
proliferation and differentiation without regard to tooth type [35].  
Isolation 
Other factors may also inﬂuence DPSC quality and quantity, including the 
speciﬁc methods used to isolate, collect, concentrate, and store these isolates once they 
are removed [16]. For example, the two most common methods used for DPSC isolation 
are enzymatic dissociation (DPSC-ED), where enzymes are used to digest the matrix and 
other biological materials comprising the dental pulp, and direct outgrowth (DPSC-OG) 
which allows for DPSCs to naturally dissociate from the pulp over the course of several 
weeks in laboratory cultures [36]. Some studies have demonstrated that DPSC-ED are 
more likely to give rise to heterogeneous populations of faster growing cells due to the 
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enzymatic activity that may facilitate release of DPSC embedded within this matrix [37]. 
However, other studies have suggested that cellular damage or destruction may result 
from using this method, suggesting that DPSC-OG may be a less a destructive 
alternative, although this tends to give rise to fewer and largely homogeneous DPSC 
populations with more limited differentiation potential [38]. Research from this group 
confirmed these findings and has used the direct outgrowth method for all subsequent 
isolation procedures [15].  
Within these heterogeneous populations of DPSC derived from the pulp of 
permanent dentition, there are more specific sub-populations that include stem cells from 
the apical papilla (SCAP), dental follicle (DFSC), periodontal ligament (PDLSC), as well 
as non-specific DPSCs [39,40]. The dental papilla contributes to tooth formation and 
becomes part of the dental pulp tissue in the mature dentition. Stem cells isolated from 
the dental papilla (SCAP) have been demonstrated to produce dentin and cementum in 
animal models and have been shown to express comparatively higher levels of the 
survivin protein, as well as a unique cell surface marker (CD24) not found in other dental 
derived stem cells [41].  
However, stem cells have also been isolated from the dental follicle, more 
specifically from the peridontium surrounding third molars prior to eruption, which are 
capable of differentiation into bone lineages with expression of osteocalcin and bone 
sialoprotein, and can be separated based upon their comparatively higher expression of 
insulin-like growth factor (IGF-2) [42]. Finally, stem cells derived from the periodontal 
ligament (PDLSC) express the biomarkers STRO-1 and CD146 and are capable of 
forming cementum-like cells, adipocytes and collagen forming cells [43]. Other research 
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from this group has confirmed these findings, suggesting that multiple sub-populations 
and lineages may be derived from dental pulp and the associated tissues that has distinct 
phenotype and differentiation capabilities and potential [44].  
Culture and Cryopreservation 
Finally, other research has suggested that ancillary factors, such as the choice of 
media, the selection of early versus late passage cells, and cryopreservation techniques 
may also influence the differentiation potential and proliferative capacity of DPSC 
isolates [45]. For example, there is some evidence to suggest that no serum (serum-free) 
media may facilitate the preferential selection and expansion of DPSC bearing specific 
stem cell biomarkers, while other studies found similar results using low or limited serum 
media [46,47]. In addition, the selection of early- versus late-passage populations may 
also preserve a more diverse array of potential DPSC sub-populations, which has been 
repeatedly confirmed in more recent studies [48-51]. Finally, some evidence suggests that 
cryopreservation methods and materials may also directly influence the survival rate and 
therapeutic potential of DPSC, suggesting more research into this area may be needed 
[52-54].  
Conclusions 
Although there are several for-profit organizations that have begun to offer 
services specific for the extraction, processing and long-term storage of DPSC, evidence 
based recommendations are limited regarding the viability and potential applications of 
DPSCs in order to provide patients (and parents) interested in banking these tissues for 
future possible usage. Due to the delicate nature of the isolation, culture and storage 
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process, extraction and processing fees, combined with the additional monthly long-term 
storage, may result in costs that exceed many thousands of dollars before (or if) these 
cells are needed. More research, however, will be needed for dental researchers and 
clinicians to more fully explore the feasibility and potential for isolating and culturing 
DPSCs extracted from adult human teeth in order to provide more accurate and informed 
advice for this newly developing ﬁeld of regenerative medicine. 
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CHAPTER 3 
METHODOLOGY 
Human Subjects 
This original protocol for this study titled “Isolation of Non-Embryonic Stem 
Cells from Dental Pulp” at the University of Nevada, Las Vegas School of Dental 
Medicine (UNLV-SDM) dental clinic was approved by the UNLV Office of Research 
Integrity Human Subjects (OPRS#0907-3148) in February 2010 [15, 16]. In brief, the 
samples for this study were isolated from patients that were randomly recruited by 
members of the UNLV-SDM clinic during their dental visits between February and June 
2010. Informed Consent was required and was conducted onsite at the time of study 
recruitment. Inclusion criteria: All patients were required to be consenting adults (> 18 
years old) who agreed to participate. In addition, all dental pulp samples were collected 
from subjects with sound, unrestored, vital teeth (teeth that have healthy pulp tissue), who 
were already scheduled to have one or more extractions that were necessary for oral 
health, as determined by the clinical faculty member in charge. Exclusion criteria: Any 
subject under eighteen (18), any subjects scheduled for dental extractions involving 
compromised pulp, and any subject that refused to donate their extracted teeth or 
participate in this study.  
DPSC Isolation and Culture 
The teeth included in this retrospective study were originally extracted due to 
impaction (e.g., third molars) or crowding (e.g., premolars extracted for orthodontic 
treatment). Following extraction, the teeth were sectioned at the cemento-enamel junction 
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(CEJ) using a diamond rotary disc and the dental pulp was removed with an endodontic 
broach and then immediately placed into sterile microcentrifuge tubes containing 1X 
phosphate buffered saline (PBS) and transferred to the laboratory for culture. Tubes were 
pre-assigned a unique, randomly-generated number to maintain patient confidentiality 
and to prevent research bias. The dental pulp samples were then transferred to a 
biomedical laboratory for processing and culture using the direct outgrowth (DPSC-OG) 
method [37, 55]. In brief, the PBS containing extracted dental pulp was centrifuged at 2.1 
relative centrifugal force (RCF) and then resuspended in 1.0 mL of RPMI-1640 medium 
from Hyclone (Logan, UT) with 2mM L-Glutamine, adjusted to contain 1.5 g/L sodium 
bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate. Media was 
supplemented with 1% Penicillin (10,000 units/mL), Streptomycin (10,000 mg/mL) 
solution and 10% fetal bovine serum (FBS), obtained from HyClone (Logan, UT). Cells 
were cultured in 75 cm2 BD Falcon tissue-culture treated flasks (Bedford, MA) at 37°C 
and 5% CO2 in humidified chambers. Media was changed every 48 hours until adherent 
cells reached 70% confluence. Cells were subsequently passaged at a 1:4 ratio for a 
minimum of ten passages. 
RNA Isolation and RT-PCR 
To determine if the cells from each dental pulp isolate (remaining after ten 
passages) were dental pulp stem cells (DPSC), RNA was isolated from 1.5 x 107 cells of 
each of the experimental cell lines, using ABgene Total RNA Isolation Reagent (Epsom, 
Surrey, UK) in accordance with the procedure recommended by the manufacturer [56]. 
RNA concentration and purity were calculated using UV spectroscopy. RT-PCR was then 
performed on total RNA using the ABgene Reverse-iT One-Step RT-PCR Kit 
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(ReadyMix Version) and a Mastercycler gradient thermocycler (Eppendorf: Hamburg, 
Germany) using the mesenchymal stem cell (MSC) primers for CD44, CD133, NANOG, 
Oct4, Sox-2, Bin1, Rnf12, and Klf4 synthesized by SeqWright (Houston, TX), as 
previously described [15,16,57]. Reaction products were separated by gel electrophoresis 
using Reliant 4% NuSieveR 3:1 Plus Agarose gels (Lonza: Rockland, ME). Bands were 
visualized by UV illumination of ethidium-bromide-stained gels and captured using a 
Kodak Gel Logic 100 Imaging System and 1D Image Analysis Software (Eastman 
Kodak: Rochester, NY). Quantitation of RT-PCR band densitometry and relative mRNA 
expression levels were performed using Adobe Photoshop (San Jose, CA) imaging 
software, Image Analysis tools. All four (4) cell lines used in this study were found at 
baseline to express intracellular (NANOG, Oct4, Sox-2, Klf4, Rnf12, Bin1) and cell 
surface markers (CD44, CD133) that are used to identify and characterize DPSC isolates. 
Baseline Growth and Doubling Time 
Assays to ascertain doubling time (DT) were performed in the appropriate 
complete media. In brief, cells at 70% confluence were trypsinized and plated 1:4 into 
new 75 cm2 BD Falcon tissue-culture treated flasks (Bedford, MA) at 37°C and 5% CO2 
in humidified chambers and their confluence was measured with a Zeiss Axiovert 40 
inverted microscope (Gottingen, Germany). Three separate, independent replications of 
each experiment were performed to determine doubling time for each DPSC isolate. 
Experimental Assays 
Proliferation and differentiation assays were performed in the appropriate 
complete media, with and without the addition of exogenous growth factors (GF) or 
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extracellular matrix (ECM), in Corning Costar 12-well assay plates (Corning, NY) at a 
concentration of 1.2 x 106 cells per well, and proliferation was measured over twenty four 
(24) days. Cultured cells were fixed at five time points, at the initial plating (T1), after six 
(6) days (T2), after twelve (12) days (T3), after (18) days (T4) and after twenty four (24) 
days (T5), using 50 mL of 10% buffered formalin. For experimental plates fixed at each 
time point, the formalin was aspirated after twenty four (24) hours and each cell well was 
then stained with crystal violet 1% aqueous solution (Fisher Scientific: Fair Lawn, NJ). 
The stain was then aspirated and wells washed with 1X phosphate buffered saline (Fisher 
Scientific: Fair Lawn, NJ) and aspirated. The relative absorbance was then measured at 
630 nm using a Bio-Tek ELx808 microplate reader (Winooski, VT). Data were analyzed 
and graphed using Microsoft Excel (Redmond, WA). Three separate, independent 
replications of each experiment were performed. 
Materials 
Two direct methods for induction of DPSC isolate differentiation in vitro were 
utilized: 1) the addition of exogenous growth factors (GF), and 2) the coating of specific 
extracellular matrix molecules (ECM) onto the surface of tissue-culture dishes, which 
were performed for each of the experimental assays described above. As previous 
research has demonstrated transforming growth factor (TGF-b1; M.W. 44.3 kDA) may, 
in fact, be critical to maintaining DPSC pluripotency, TGF-b1 was obtained from 
Calbiochem (La Jolla, CA) and the cellular media supplemented to a final concentration 
of 2.5 ng/mL or 0.56 uM [18]. In addition, one of the primary methods for GF induced 
differentiation of DPSC and MSC isolates, Dexamethasone (Dex) was obtained from 
Fisher Scientific (Fair Lawn, NJ) and added to cellular media for a final concentration of 
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10 nM [58,59]. Finally, the control for the GF experiments was the MEK1 inhibitor (40 
ng/mL or 50 mM), a cell-cycle and growth factor inhibitor, obtained from 
Calbiochem/EMD Biosciences/Millipore, M.W. 267.3 (Darmstadt, Germany) [57]. 
Extracellular matrix (ECM) molecules were obtained from Fisher Scientific (Fair Lawn, 
NJ) and tissue culture wells were coated with purified ECM at a 20 ug/mL protein 
concentration for one hour (60 minutes) at room temperature (25 C), as previously 
described. Poly-L-lysine (34-382-0001), Collagen-1 (50- 361-599) and Laminin-5 
(NC9992259) [59-62]. Data were analyzed and graphed using Microsoft Excel 
(Redmond, WA).  
Statistical Analysis 
The differences between treatments were measured using a t distribution, p= 0.05. 
All samples were analyzed using two-tailed t-tests as departure from normality can make 
more of a difference in a one-tailed than in a two-tailed t-test [63]. As long as the sample 
size is at least moderate (>20) for each group, quite severe departures from normality 
make little practical difference in the conclusions reached from these analyses.  
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CHAPTER 4 
RESULTS 
Four (4) previously characterized dental pulp stem cell lines were thawed and 
subsequently grown in culture to assess their baseline growth and doubling time (Figure 
1) [15,16]. The average doubling time was 2.83 days, which ranged between 2.05 to 3.87 
days. For the in vitro differentiation experiments, each cell line (DPSC-3882, 5653, 9765, 
and 11418) was then plated into 96-well tissue culture treated plates and evaluated using 
photomicroscopy to determine any changes to cellular morphology, as well as cellular 
number and doubling time. In these 24-day assays, from the initial time point (T1) to the 
final endpoint (T5), each of the four DPSC cell lines grew from less than 5% confluence 
(Figure 3) to approximately 34% confluence (Figure 1). The addition of TGF-b1, recently 
demonstrated to maintain or increase pluripotency in DPSC, was associated with 
accelerated growth of approximately 55% in these cell lines (Figure 2) [58, 59]. The 
average doubling time decreased by 27.3% from 2.83 to 2.2 days, ranging between 1.1 to 
4.09 days. Although doubling time in one cell line (DPSC-5653) did not exhibit a 
significant change (3.87 to 4.09 days), doubling time in DPSC-9765 (2.18 to 1.14 days), 
DPSC- 3882 (3.24 to 2.22 days), and DPSC-11418 (2.05 to 1.35 days) decreased 
markedly (n=24, p<0.05). Although significant changes to the rates of cellular growth 
were observed with the addition of TGF-b1, no overt changes to cellular morphology or 
size were observed in any cell line (Figure 3). Following previous research that 
demonstrated induction of MSC and DPSC differentiation in vitro using specific 
extracellular matrix (ECM) molecules and growth factors, these methods were utilized to 
ascertain any effects on cellular phenotype or growth in these DPSC isolates (Figure 4) 
16 
 
[58-62]. The addition of growth factors to the cell culture medium induced variable 
responses in the DPSC isolates. As previously noted, TGF-b1 increased the doubling time 
and proliferation in all DPSC isolates by approximately 50% (range: 1.32 – 1.91 fold 
increase), although no overt changes to cellular morphology were observed. The addition 
of the MEK1 inhibitor PD98059 was not sufficient to induce any overt changes to any of 
the DPSC isolates (Figure 5). However, the addition of Dexamethasone (Dex) was 
sufficient to induce a differential response in DPSC-9765 and DPSC-11418, but not in 
DPSC-3882 or DPSC-5653 (Figure 6). More specifically, growth in DPSC-9765 was 
increased by 2.03 fold while proliferation of DPSC-11418 increased by 2.31 fold, which 
was significantly higher than the growth observed in DPSC-3882 or DPSC-5653 
(p<0.05), which was also correlated with changes to cellular morphology and the 
formation of dense accumulations of localized, site-specific aggregations of larger cells 
with visibly altered morphology. 
 The wells coated with the ECM control poly (PLL) (Figure 7) and the 
experimental wells coated with Collagen 1 (CG1) did not induce any changes to cell 
number or morphology in any of the four cell lines (Figure 8). However, a differential 
response was noted in the wells coated with Laminin-5 (LN5) with two DPSC isolates 
exhibiting both an increase in cell number, as well as significant changes to the 
morphology of some subsets of cells. More specifically, LN5 was sufficient to induce an 
increase in growth in DPSC-3882 and DPSC-5653 by more than two-fold (2.24 and 2.29 
respectively), which was significantly different than the growth observed in the other 
DPSC isolates and from the baseline measurements (p< 0.05) (Figure 9). 
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In order to evaluate and assess the differential phenotypic changes observed under 
Dexamethasone administration and Laminin-5 plating, RNA was successfully isolated 
from all DPSC isolates under conditions and relative endpoint (RE) reverse transcription 
polymerase chain reaction (RT-PCR) was performed using equal concentrations of total 
RNA from each isolate. These analyses revealed that mRNA specific for the intracellular 
biomarkers for DPSC, Klf4 and Sox well as the cell surface marker CD133, were 
expressed in DPSC-3882, DPSC-5653, DPSC-9765 and baseline. Additional mRNA 
biomarkers, including Bin Rnf12, Oct-4 and NANOG were also expressed (Figures 10-
14). The relative levels of these intracellular and extracellular biomarkers were enhanced 
following the administration of TGF-β1. However, the differential phenotypes observed 
under Dexamethasone and Laminin administration were associated with differential 
expression of these same biomarkers.  
More specifically, the altered the growth and phenotype of DPSC-9765 and 
DPSC-11418 following Dexamethasone administration was correlated with a loss of 
mRNA for the transcriptional control regulator Klf4 (as well as Bin1 and Rnf12). In 
addition, expression of mRNA specific for the downstream biomarkers Sox-2 (as well as 
Oct4 and NANOG) and CD133 was also down-regulated with previous observations of 
apical papilla (AP) dental follicle (DF) derived DPSCs that are responsive to GF induced 
methods for in vitro differentiation. However, no significant changes to these biomarkers 
were observed in either DPSC-3882 or DPSC-5653, the DPSC isolates non-responsive to 
Dexamethasone.  
Conversely, the altered phenotypes observed in DPSC-3882 and DPSC-5653 
following plating on Laminin-5 coated dishes were associated with a downregulation (but 
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not loss) of mRNA expression in both Klf4 and Sox-2 (as well as Bin1, Rnf12, Oct4, and 
NANOG; (Figures 10-12). Expression of mRNA for the downstream cell surface DPSC 
biomarker CD133, however, was only slightly reduced in the DPSC-3882 isolate, 
although this expression was completely lost in DPSC-5653. These results appear to be 
consistent with previous observations that periodontal ligament (PD)-derived DPSC 
isolates may be primarily responsive to ECM-mediated methods for in vitro 
differentiation.  
CHAPTER 5 
DISCUSSION AND CONCLUSIONS 
Discussion 
The goal of this project was to evaluate the potential to induce differentiation 
among DPSC isolates from four (4) orthodontic patients using established MSC and 
DPSC protocols and methods. These results demonstrated that all four DPSC isolates 
exhibited phenotypes and expressed biomarkers at baseline consistent with MSC and 
DPSC and also responded appropriately to the pluripotency sustaining effects of in vitro 
TGFb1 administration [58, 59]. However, the two primary methods for inducing 
differentiation, ECM plating and GF administration [58-62], exhibited differential 
responses in these DPSC isolates. That these DPSC isolates were susceptible to the 
effects of either ECM- or GF-induced alterations to growth, proliferation, morphology 
and DPSC biomarker expression, suggests that these methods may be sufficient to 
stimulate these responses in some DPSC isolates, although not universally. More 
importantly, that the specific type of DPSC isolate (influenced by the method of isolation 
and culture) may be, in fact, a critical component for a more complete understanding of 
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how these methods could be employed to evaluate the potential lineages and usages for 
any given patient [14,37,55]. For example, these findings complement the ever expanding 
body of research that suggests DPSC isolates are often not heterogeneous aggregations of 
DPSCs but may, in fact, be clones derived from different and often very specific subsets 
of DPSCs, such as AP-DPSC, DF-DPSC or PDL-DPSC [37,55]. Many factors influence 
DPSC quality and quantity and type, including the methods used to isolate, collect, 
concentrate, and store these isolates [1]. For instance, isolation by enzymatic dissociation 
(DPSC-ED) may be more likely to produce heterogeneous populations of faster growing 
cells, as this process allows for dissociation of multiple cell types from the extracted 
dental pulp, although this process may limit viability and may also decrease overall yield 
[11,14]. In contrast, DPSC isolation by direct outgrowth (DPSC-OG), the method 
employed in this study, tends to produce largely homogenous populations of one DPSC 
type, with more limited differentiation potential due to their random selected clonal 
derivation [15, 16]. This study had several limitations that should be outlined, including a 
very limited sample size (n=4), which may restrict the overall ability to make inferences 
about these results. In addition, the DPSC isolates were derived from adult orthodontic 
patients, which may have different health outcomes and parameters than other dental 
patient populations, which could also influence the overall results and outcomes 
associated with this study [56]. Finally, this was a retrospective analysis of previously 
collected DPSC isolates, therefore, prospective studies that incorporate larger sample 
sizes will be needed to further elucidate the parameters that most likely influence the 
differentiation potential for DPSC isolates from dental patients.  
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Conclusions 
Although some commercial enterprises now offer DPSC banking and storage 
services, much less is known about the viability or potential applications for DPSCs 
isolated from dental patients. Although many patients routinely have intact, adult teeth 
extracted for orthodontic and other dental-related issues, few studies have addressed the 
potential to characterize the potential for these isolates to be manipulated in laboratory 
settings. This study provides some initial evidence that randomly selected DPSC isolates 
from orthodontic patients may be induced by established protocols to change phenotype 
and expression of pluripotent biomarkers with variable susceptibility between differing 
types of DPSCs, although more studies will be needed to determine the range of cell 
types that can be successfully re-engineered in laboratory settings. 
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Recommendations for further research 
Stem Cell therapy is being used to treat life threatening conditions around the 
world, and the full breath of stem cell therapy has only just begun to be discovered. In the 
last several years there has been a tremendous increase in our knowledge of 
bioengineering of DPSCs. The usefulness of these cells is being uncovered exponentially 
as researchers work together as a multidisciplinary team across many fields to continue 
progress in this work. In this study and in others across the world, we are seeing evidence 
that suggests that tissue regeneration is no longer an unattainable dream. The application 
of this knowledge in medicine and dentistry will allow practitioners to increase the 
quality of life for mankind.  
This work is among the first to demonstrate that Dexamethasone and Laminin-5 
may be sufficient to induce partial DPSC differentiation. It is also among the first to show 
that TGF-β1 notably increases pluripotency in DPSCs. The search for the ideal 
combination of cells, scaffolds, and morphogenic factors for the engineering of tissues 
from DPSCs is the focus of immediate future research. Using the knowledge we have 
gained in this study, it seems natural to move forward with the combination of the 
substrates we have used to see how differentiation of DPSCs occurs through these 
modalities. Prospective studies including multiple DPSC lines could be exposed to both 
Dexamethasone and TGF-β1, and Laminin-5 and TGF-β1 in combination to observe the 
changes in the cells. It would be interesting to observe if the increased pluripotency we 
noted with exposure to TGF-β1 would induce increase number of cells that differentiated 
or if the speed of differentiation changed when DPSCs are exposed to these proposed 
combinations of substrates. Once clear protocols are established that allow for predictable 
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differentiation of cells into specific tissue forming cells, work can begin on advances that 
will likely progress into the biologic regeneration of oral tissues such as producing a 
scaffold to induce tissue growth into a particular shape and/or laying down of patterns of 
homeobox genes within these scaffolds to induce formation of layers of tissues. The 
future of research in this discipline is exciting and the advances that will unfold in the 
next decade will bring much progression in medicine and dentistry. 
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APPENDIX A 
FIGURES RELATED TO THE RESEARCH QUESTIONS 
 
 
Figure 1/ Figure 2. Base line DPSC proliferation is enhanced in vitro by the addition of 
TGF B1. Initial plating of cells (T1) revealed an average confluence of approximately 
5%. Baseline growth (without the addition of growth factors) demonstrated an average 
doubling time of 2.83 days (DPSC-5633: 3.87d; DPSC-3882: 3.24 d; DPSC-11418: 
2.05d) for a final confluence at the final time point (T5) of approximately 34%. (Figure 
1) The addition of TGF-B1 increased growth at T5 to approximately 53% and decreased 
average doubling time to 2.21 days (DPSC-9765: 1.14d; DPSC-5653; 4.09 d; DPSC-
3882: 2.22d; DPSC-11418: 1.35 d). (Figure 2). 
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Figure 3. The addition of TGF-β1was associated with accelerated growth of 
approximately 55% in all four cell lines. Although significant changes to the rates of 
cellular growth were observed with the addition of TGF- β1, no overt changes to cellular 
morphology or size were observed in any cell line. 
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Figure 4. DPSC cellular phenotypes altered by exogenouf factors. The addition of 
extracellular matrix coated wells or growth factor was sufficient to indue changes to 
some DpSC isoates. As previously noted, TGF-β1 increased growth in all four isolates 
with no changes observed in cellular morphology. 
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Figure 5.  Base line DPSC plated with MEK 1 Inhibitor (T1). No change seen in cell 
morphology over time points (T3) and (T5). 
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Figure 6.  Base line DPSC plated with Dexamethasone (T1).Significant changes to 
cellular morphology and increased growth over time points (T3) and (T5) was seen in cell 
lines DPSC 9765 and DPSC 11418. 
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Figure 7.  Base line DPSC plated with Poly-L-lysine (T1). No change seen in cell 
morphology over time points (T3) and (T5). 
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Figure 8.  Base line DPSC plated with Collagen and Vitronectin (T1). No change seen in 
cell morphology over time points (T3) and (T5). 
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Figure 9.  Base line DPSC plated with Laminin 5 (T1).Significant changes to cellular 
morphology and increased growth over time points (T3) and (T5) was seen in cell lines 
DPSC 3882 and DPSC 5653. 
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Figure 10. The addition of extrcellular matrix Laminin-5 coated wells was sufficient to 
inhibit Cox-4 and Sox-2 intracellular mRNA expression in DPSC-3882 and DPSC-5653 
cell lines. 
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Figure 11. The addition of extrcellular matrix Laminin-5 coated wells was sufficient to 
inhibit Rnf, Bin, and Klf intracellular mRNA expression in DPSC-3882 and DPSC-5653 
cell lines. 
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Figure 12. The addition of extrcellular matrix Laminin-5 coated wells was sufficient to 
inhibit CD133 cell surface marker expression in DPSC-3882 and DPSC-5653 cell lines. 
CD44 (Control) cell surface marker was maintained. 
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Figure 13. The addition of growth factor Dexamethasone was sufficient to inhibit Sox-2 
intracellular mRNA expression in DPSC-9765 and DPSC-11418 cell lines. Oct-4 
expression was altered with an alternative (shorter) transcript expressed and at 
significantly higher levels. 
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Figure 14. The addition of growth factor Dexamethasone was sufficient to inhibit Rnf, 
Bin, and Klf intracellular mRNA expression in DPSC-9765 and DPSC-11418 cell lines. 
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